Skip to main content

Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.

Publication ,  Journal Article
de Blank, P; Li, N; Fisher, MJ; Ullrich, NJ; Bhatia, S; Yasui, Y; Sklar, CA; Leisenring, W; Howell, R; Oeffinger, K; Hardy, K; Okcu, MF ...
Published in: Genet Med
November 2020

PURPOSE: Neurofibromatosis type 1 (NF1) is associated with tumor predisposition and nonmalignant health conditions. Whether survivors of childhood cancer with NF1 are at increased risk for poor long-term health outcomes is unknown. METHODS: One hundred forty-seven 5+ year survivors of childhood glioma with NF1 from the Childhood Cancer Survivor Study were compared with 2629 non-NF1 glioma survivors and 5051 siblings for late mortality, chronic health conditions, and psychosocial, neurocognitive, and socioeconomic outcomes. RESULTS: Survivors with NF1 (age at diagnosis: 6.8 ± 4.8 years) had greater cumulative incidence of late mortality 30 years after diagnosis (46.3% [95% confidence interval: 23.9-62.2%]) compared with non-NF1 survivors (18.0% [16.1-20.0%]) and siblings (0.9% [0.6-1.2%]), largely due to subsequent neoplasms. Compared with survivors without NF1, those with NF1 had more severe/life-threatening chronic conditions at cohort entry (46.3% [38.1-54.4%] vs. 30.8% [29.1-32.6%]), but similar rates of new conditions during follow-up (rate ratio: 1.26 [0.90-1.77]). Survivors with NF1 were more likely to report psychosocial impairments, neurocognitive deficits, and socioeconomic difficulties compared with survivors without NF1. CONCLUSIONS: Late mortality among glioma survivors with NF1 is twice that of other survivors, due largely to subsequent malignancies. Screening, prevention, and early intervention for chronic health conditions and psychosocial and neurocognitive deficits may reduce long-term morbidity in this vulnerable population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Genet Med

DOI

EISSN

1530-0366

Publication Date

November 2020

Volume

22

Issue

11

Start / End Page

1794 / 1802

Location

United States

Related Subject Headings

  • Survivors
  • Retrospective Studies
  • Outcome Assessment, Health Care
  • Neurofibromatosis 1
  • Neoplasms
  • Morbidity
  • Humans
  • Glioma
  • Genetics & Heredity
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
de Blank, P., Li, N., Fisher, M. J., Ullrich, N. J., Bhatia, S., Yasui, Y., … Krull, K. R. (2020). Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genet Med, 22(11), 1794–1802. https://doi.org/10.1038/s41436-020-0873-7
Blank, Peter de, Nan Li, Michael J. Fisher, Nicole J. Ullrich, Smita Bhatia, Yutaka Yasui, Charles A. Sklar, et al. “Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.Genet Med 22, no. 11 (November 2020): 1794–1802. https://doi.org/10.1038/s41436-020-0873-7.
de Blank P, Li N, Fisher MJ, Ullrich NJ, Bhatia S, Yasui Y, et al. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genet Med. 2020 Nov;22(11):1794–802.
de Blank, Peter, et al. “Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.Genet Med, vol. 22, no. 11, Nov. 2020, pp. 1794–802. Pubmed, doi:10.1038/s41436-020-0873-7.
de Blank P, Li N, Fisher MJ, Ullrich NJ, Bhatia S, Yasui Y, Sklar CA, Leisenring W, Howell R, Oeffinger K, Hardy K, Okcu MF, Gibson TM, Robison LL, Armstrong GT, Krull KR. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genet Med. 2020 Nov;22(11):1794–1802.

Published In

Genet Med

DOI

EISSN

1530-0366

Publication Date

November 2020

Volume

22

Issue

11

Start / End Page

1794 / 1802

Location

United States

Related Subject Headings

  • Survivors
  • Retrospective Studies
  • Outcome Assessment, Health Care
  • Neurofibromatosis 1
  • Neoplasms
  • Morbidity
  • Humans
  • Glioma
  • Genetics & Heredity
  • Child